Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by Mickey7on Mar 10, 2015 11:58am
69 Views
Post# 23505737

RE:NEWSS!

RE:NEWSS!

sure is a great deal espeically with the top opthamalogy company in the USA, on top of that they are looking forward to more deals and there are tons of people out there who could use treatment! could have a nice run here volume running up

We expect to continue putting into place additional nonexclusive agreements in the Unites States and in many other countries."

There are millions of diabetic and pre-diabetic patients in the United States who do not routinely have their eyes screened for vision problems associated with diabetes1. Diabetic retinopathy screening can make a major contribution towards improving their quality of life by identifying patients with unknown eye disorders and referring them for appropriate medical follow up2


Read more at https://www.stockhouse.com/companies/bullboard/v.adk/diagnos-inc#M58Q3XLfKYhpURUx.99
Bullboard Posts